News Posts List
Increasing reactive oxygen species as a therapeutic approach to treat hereditary leiomyomatosis and renal cell carcinoma
03/15/2012
Hereditary leiomyomatosis renal cell carcinoma (HLRCC)-associated renal tumors are aggressive and tend to metastasize early. There are currently no effective forms of therapy for patients with advanced HLRCC-associated kidney cancer.
Congressional oversight over the 340B program
03/15/2012
A March 8, 2012 National Patient Advocate Foundation (NPAF) letter applauds Congressional efforts to better understand how the 340B program operates as it relates to the risk of improper purchases or diversion of 340B drugs, to facilitate Congressional oversight over the 340B program, and to ensure the 340B program is operating within the parameters of the law.
You're Invited: Join Kidney Cancer's New Global Congress!
03/15/2012
Welcome to KidneyCancerCongress.org, where we are building the world's largest coalition of kidney cancer advocates. We are already collaborating with people in Russia, Poland, France, Italy, Singapore, United States, United Kingdom, and many other countries. Anyone with an interest in eradicating death and suffering from renal cancers is welcome to join.
Outcome predictors of Gamma Knife radiosurgery for RCC
03/14/2012
To evaluate the role of stereotactic radiosurgery (SRS) in the management of brain metastases from renal cell carcinoma.
Kidney Cancer Association requests call to Congress
03/14/2012
We've made it easy for people to join this effort using a simple online tool, says KCA Chief Executive, Bill Bro, a 22-year kidney cancer survivor.
India uses arm-twist rule for cancer drug
03/14/2012
New Delhi, March 12: India has for the first time exercised its legal right to arm-twist pharmaceutical companies to make available expensive, patented medicines at a lower cost, allowing the generic manufacture of a cancer drug owned by a foreign company.
Tumor Disappearance Following Radiation
03/13/2012
The phenomenon reported by the researchers, known as the abscopal effect, occurs when localized radiation therapy delivered to a single tumor in a patient with advanced disease results in tumor disappearance outside of the irradiated area. Though the abscopal effect is extremely rare, it has been described in several cancers including melanoma, lymphoma, and kidney cancer.
Three 'targeted' cancer drugs raise fatal side effect risk
03/10/2012
Treatment with three relatively new "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects.
Is Cancer Outwitting Personalized Medicine?
03/08/2012
Discovery of many genetic mutations within one cell may dash hopes for targeted treatments.
Novel Therapies for Metastatic Renal Cell Carcinoma
03/07/2012
With six agents approved for metastatic renal cell carcinoma (mRCC) within the past 5 years, there has undoubtedly been progress in treating this disease. However, the goal of cure remains elusive, and the agents nearest approval (i.e., axitinib and tivozanib) abide by the same paradigm as existing drugs (i.e., inhibition of VEGF or mTOR signaling).
News Feed